Back
Nationwide Nasdaq-100® Risk-MngdETF Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
55
NUSI
Nationwide Nasdaq-100® Risk-MngdETF
Last Price:
25.28
Seasonality Move:
3.41%
Buy
82
MDGL
Madrigal Pharmaceuticals
Last Price:
331.02
Seasonality Move:
31.67%
Buy
55
Nationwide Nasdaq-100® Risk-MngdETF (NUSI)
is a Buy
Is Nationwide Nasdaq-100® Risk-MngdETF a Buy, Sell or Hold?
- The current Nationwide Nasdaq-100® Risk-MngdETF [NUSI] share price is $25.31. The Score for NUSI is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- NUSI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
82
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $319.58. The Score for MDGL is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
NUSI Stock Price Chart
What is Nationwide Nasdaq-100® Risk-MngdETF's stock price today?
-
The Nationwide Nasdaq-100® Risk-MngdETF share price today is $25.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUSI is experiencing slight selling pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $319.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
NUSI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 41.74 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.38 - 25.74) | Sell |
Bollinger Bands (100): | (24.54 - 25.72) | Buy |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.37 | Buy |
Relative Strength Index (14 RSI): | 85.5 | Buy |
Chaikin Money Flow: | 2945933 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (194.64 - 241.02) | Buy |
Bollinger Bands (100): | (221.59 - 279.03) | Buy |
NUSI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.45 | Sell |
20-day SMA: | 25.58 | Sell |
50-day SMA: | 25.29 | Buy |
200-day SMA: | 24.28 | Buy |
8-day EMA: | 25.45 | Sell |
20-day EMA: | 25.49 | Sell |
50-day EMA: | 25.32 | Sell |
200-day EMA: | 24.24 | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 230.72 | Buy |
20-day SMA: | 219.8 | Buy |
50-day SMA: | 228.31 | Buy |
200-day SMA: | 241.11 | Buy |
8-day EMA: | 244.62 | Buy |
20-day EMA: | 228.06 | Buy |
50-day EMA: | 230.04 | Buy |
200-day EMA: | 234.49 | Buy |
Nationwide Nasdaq-100® Risk-MngdETF Earnings Growth & NUSI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.19 per share, and an increase next year of $9.06 per share.
Nationwide Nasdaq-100® Risk-MngdETF Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |